Figure 3.
Identification and validation of the biomarkers. (A) RF algorithm analysis. (B) LASSO regression analysis. (C) Venn plot exhibiting the biomarkers. (D) The visualization of the ANN diagnostic model. (E) The assessment result of the GSE11882 and the testification result of the GSE1572. (F) GSVA analysis of CX3CL1, APLNR, C3AR1 and ADM.